Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML
Status:
Unknown status
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether Fludarabine in combination with cytarabine
is more effective than high-dose cytarabine in post-remission therapy for patients with
core-binding factor acute myeloid leukemia
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine